Nextech
@NextechInvest
Followers
326
Following
730
Media
19
Statuses
289
Finding and fueling tomorrow’s advances in precision medicine.
Zurich, Switzerland
Joined April 2017
RT @SimonRead0: Big day today at Mariana Oncology! My sincere thanks to all my colleagues, board members and investors who made the company….
0
9
0
RT @Context_Tx: Today, we announced a $100 million private placement. This financing, together with Context's existing cash and cash equiva….
0
2
0
RT @schroederthilo: $RVMD and $EQRX merge to build a Ras powerhouse.
globenewswire.com
Revolution Medicines Expects to Conduct Late-Stage Development of RAS(ON) Inhibitor Drug Candidate Pipeline Supported by Fortified Balance Sheet Agreement...
0
1
0
RT @schroederthilo: Congrats @oricpharma.and @JacobChackoMD on closing this PIPE. It also marks @NextechInvest first PIPE investment. We ar….
globenewswire.com
Financing led by Nextech and includes participation from EcoR1 Capital, Frazier Life Sciences, Venrock Healthcare Capital Partners, and Boxer Capital Pro...
0
1
0
RT @fredhutch: Congratulations to Fred Hutch's Dr. Phil Greenberg on his election to @theNASciences! Greenberg is an internationally-recogn….
0
5
0
Thank you @Nasdaq for highlighting our recent financing of Alpha-9. Great team, science and syndicate!
0
1
2
RT @NobelPrize: "I think success is having a career where you enjoy it so much that you almost feel guilty that people pay you to do it bec….
0
233
0
RT @LoweLabMSKCC: Farewell to our latest graduate, Dr. @StellaPaff, and best of luck for her next endeavor @NextechInvest! #LoweLab25 https….
0
1
0
RT @KauffmanFellows: So grateful for the incredible LPs who joined our healthcare SIG this afternoon and shared how venture firms can creat….
0
1
0
RT @statnews: IDRx is starting off with $122 million and two licensed drug candidates it plans to combine to create a treatment for gastroi….
0
3
0
RT @JorgeCondeBio: IDRx is launching w/ $122m to treat cancer with ‘purpose-built’ precision combination therapies. @a16z is thrilled to c….
0
3
0
RT @ArrakisTx: At Arrakis, we have a simple but powerful vision: To extend medicines into new realms of biology by discovering and developi….
0
1
0
RT @pmvpharma: We are thrilled to announce our collaboration with Merck to evaluate PC14586 in combination with Merck’s anti-PD-1 therapy K….
globenewswire.com
Combination trial to be initiated in Q4 2022...
0
2
0
RT @ambagontx: Please join us in congratulating our Co-Founder, Luc Brunsveld, on his election to the Royal Dutch Academy of Sciences. Beyo….
0
1
0
RT @ambagontx: This week our CSO, @NanPry, is at the second Annual Induced Proximity-Based Drug Discovery Summit in Boston to share the lat….
0
2
0
RT @moma_tx: We're excited to announce the completion of our Series B financing, advancing our novel #drugdiscovery platform to develop pre….
0
5
0
RT @schroederthilo: Fueling the motors!.Great sign of life in this market. Strong science will always get funded. We believe in #biotech. W….
0
1
0
RT @C4Therapeutics: Today we announced clinical data from our ongoing Phase 1/2 clinical trial of CFT7455 for the treatment of multiple mye….
0
3
0